Self-monitoring of blood glucose protocol cuts hs-CRP

March 7, 2013
Self-monitoring of blood glucose protocol cuts hs-CRP
Among patients with poorly controlled type 2 diabetes, a structured self-monitoring of blood glucose protocol correlates with reductions in the level of high-sensitivity C-reactive protein, according to a study published online Feb. 22 in Diabetes Care.

(HealthDay)—Among patients with poorly controlled type 2 diabetes, a structured self-monitoring of blood glucose (SMBG) protocol correlates with reductions in the level of high-sensitivity C-reactive protein (hs-CRP), according to a study published online Feb. 22 in Diabetes Care.

Oliver Schnell, M.D., from Helmholtz Center Munich, and colleagues examined the effect of a structured SMBG protocol and associated changes in on changes in hs-CRP among 483 poorly-controlled, insulin-naive patients with type 2 diabetes. Participants were randomly allocated to active control or structured testing (STG), including quarterly structured SMBG.

At three, six, and 12 months, the researchers found that there were significantly greater reductions in the geometric mean hs-CRP in the STG group than the active control group. Significantly greater reductions in hs-CRP level were seen for patients in the STG group at high , compared with patients in the active control group at high cardiovascular risk. In both groups there was a strong correlation between reductions in hs-CRP and hemoglobin A1c.

"Our study is the first to report a relationship between the significant glycemic outcomes of a structured SMBG intervention and changes in hs-CRP, a clinical marker of cardiovascular risk," the authors write.

Two authors disclosed to Roche Diagnostics, which funded the study.

Explore further: Structured exercise training associated with improved glycemic control for patients with diabetes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Bolus calculation, flexible insulin up diabetes control

February 24, 2012

(HealthDay) -- A structured course teaching the benefits of automated bolus calculator (ABC) use and flexible intensive insulin therapy (FIIT) improves metabolic control and satisfaction in patients with type 1 diabetes, ...

Isomaltulose doesn't improve glycemic control in diabetes

April 13, 2012

(HealthDay) -- For patients with type 2 diabetes, substitution of sucrose with isomaltulose is not associated with improved glycemic control (measured by hemoglobin A1c [HbA1c] levels) at 12 weeks, according to a study published ...

Recommended for you

Engineered hot fat implants reduce weight gain in mice

August 20, 2015

Scientists at the University of California, Berkeley, have developed a novel way to engineer the growth and expansion of energy-burning "good" fat, and then found that this fat helped reduce weight gain and lower blood glucose ...

Promising progress for new treatment of type 1 diabetes

July 30, 2015

New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports, reveals that administration ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.